Biostage, Inc. BSTG
Set alert
As of Jul 19, 3:14 PM ET
52-week range unavailable
- Open
- 4.09
- Prev close
- 4.03
- Mkt cap
- 57.82M
- Vol
- 4.53K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.00
- High
- 4.14
- Forward P/E
- -0.22
- Beta
- -0.82
- Short ratio
- 3.17
- Inst. own
- 13.65%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 12, 2023
- 50-d avg
- 0.198886
- 200-d avg
- 0.324493
- 1y target
- 3.00
News
6 months ago defenseworld.net
Contrasting Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) & Biostage (OTCMKTS:BSTG)
Defiance Daily Target 2X Long LMND ETF (NASDAQ: LMNX - Get Free Report) and Biostage (OTCMKTS:BSTG - Get Free Report) are both small-cap medical companies, but which is the superior business? We will…
7 months ago defenseworld.net
Financial Analysis: Biostage (OTCMKTS:BSTG) and T2 Biosystems (NASDAQ:TTOO)
T2 Biosystems (NASDAQ: TTOO - Get Free Report) and Biostage (OTCMKTS:BSTG - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two…
11 months ago defenseworld.net
Critical Comparison: Arch Therapeutics (OTCMKTS:ARTH) vs. Biostage (OTCMKTS:BSTG)
Arch Therapeutics (OTCMKTS:ARTH - Get Free Report) and Biostage (OTCMKTS:BSTG - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two…
3 years ago prnewswire.com
Biostage Activated Mayo Clinic as The First Site for Clinical Trial in Severe Esophageal Disease
HOLLISTON, Mass. , July 18, 2023 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a clinical-stage biotechnology company developing the technology to regenerate organs…
3 years ago prnewswire.com
Biostage Selects IQVIA to Manage its FDA-Approved Clinical Trial in Severe Esophageal Disease, including Cancer
IQVIA was selected because of its dedicated gastrointestinal team and depth of experience in running cell-therapy clinical trials. HOLLISTON, Mass.
3 years ago seekingalpha.com
Biostage, Inc. (BSTG) Q3 2022 Earnings Call Transcript
Biostage, Inc. (OTC:BSTG) Q3 2022 Earnings Conference Call November 15, 2022 9:00 AM ET Company Participants David Green - Interim Chief Executive Officer Joe Damasio - Chief Financial Officer…
4 years ago prnewswire.com
Biostage Schedules Conference Call and Webcast for Q2 2022 Results
HOLLISTON, Mass. , Aug. 4, 2022 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a cell-therapy biotechnology company with successful "first-in-human" experience in…
4 years ago seekingalpha.com
Biostage Begins U.S. Uplisting IPO Rollout
Biostage has filed to raise capital via an uplisting IPO to Nasdaq. The firm is developing treatments for the various gastrointestinal system and airway conditions.
4 years ago seekingalpha.com
Biostage, Inc. (BSTG) Interim CEO David Green on Q1 2022 Results - Earnings Call Transcript
Biostage, Inc. (OTC:BSTG) Q1 2022 Earnings Conference Call May 17, 2022 8:30 AM ET Company Participants Peter Pellegrino - Interim Vice President of Finance David Green - Interim Chief Executive…
4 years ago prnewswire.com
Biostage Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2021 Financial Results
HOLLISTON, Mass. , March 30, 2022 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a cell-therapy biotechnology company with successful "first-in-human" experience in…
-
4 years ago benzinga.com
5 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their…
5 years ago prnewswire.com
Biostage Reports Q2 2021 Financial Results
HOLLISTON, Mass., Aug. 13, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal implants based its novel…
5 years ago prnewswire.com
Biostage Reports Q1 2021 Financial Results
HOLLISTON, Mass., May 24, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal implants based its novel…
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
Stocks That Hit 52-Week Highs On Thursday
-
9 years ago benzinga.com
35 Stocks Moving In Thursday's Mid-Day Session
35 Stocks Moving In Thursday's Mid-Day Session